Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet Oncol. 2016 Jan;17(1):78-89. doi: 10.1016/S1470-2045(15)00366-6. Epub 2015 Nov 16.
Lancet Oncol. 2016.
PMID: 26590673
Free article.
Clinical Trial.
Simulation-based adjustment after exploratory biomarker subgroup selection in phase II.
Götte H, Kirchner M, Sailer MO, Kieser M.
Götte H, et al. Among authors: sailer mo.
Stat Med. 2017 Jul 10;36(15):2378-2390. doi: 10.1002/sim.7294. Epub 2017 Apr 24.
Stat Med. 2017.
PMID: 28436046
Item in Clipboard
On confidence intervals for the hazard ratio in randomized clinical trials.
Lin DY, Dai L, Cheng G, Sailer MO.
Lin DY, et al. Among authors: sailer mo.
Biometrics. 2016 Dec;72(4):1098-1102. doi: 10.1111/biom.12528. Epub 2016 Apr 28.
Biometrics. 2016.
PMID: 27123760
Free PMC article.
Item in Clipboard
Probability of success for phase III after exploratory biomarker analysis in phase II.
Götte H, Kirchner M, Sailer MO.
Götte H, et al. Among authors: sailer mo.
Pharm Stat. 2017 May;16(3):178-191. doi: 10.1002/pst.1804. Epub 2017 Feb 23.
Pharm Stat. 2017.
PMID: 28230320
Item in Clipboard
Pharmacometrics enhanced Bayesian borrowing approach to improve clinical trial efficiency: Case of empagliflozin in type 2 diabetes.
Fayette L, Sailer MO, Perez-Pitarch A.
Fayette L, et al. Among authors: sailer mo.
CPT Pharmacometrics Syst Pharmacol. 2023 Oct;12(10):1386-1397. doi: 10.1002/psp4.13035. Epub 2023 Aug 30.
CPT Pharmacometrics Syst Pharmacol. 2023.
PMID: 37644910
Free PMC article.
Item in Clipboard
Duration of and time to response in oncology clinical trials from the perspective of the estimand framework.
Weber HJ, Corson S, Li J, Mercier F, Roychoudhury S, Sailer MO, Sun S, Todd A, Yung G; Industry Working Group on Estimands in Oncology.
Weber HJ, et al. Among authors: sailer mo.
Pharm Stat. 2024 Jan-Feb;23(1):91-106. doi: 10.1002/pst.2340. Epub 2023 Oct 2.
Pharm Stat. 2024.
PMID: 37786317
Item in Clipboard
Propensity score stratified MAP prior and posterior inference for incorporating information across multiple potentially heterogeneous data sources.
Zhu AY, Roy D, Zhu Z, Sailer MO.
Zhu AY, et al. Among authors: sailer mo.
J Biopharm Stat. 2024 Mar;34(2):190-204. doi: 10.1080/10543406.2023.2181354. Epub 2023 Mar 7.
J Biopharm Stat. 2024.
PMID: 36882957
Item in Clipboard
Cite
Cite